Skip to main content
. Author manuscript; available in PMC: 2008 Oct 6.
Published in final edited form as: Psychopharmacology (Berl). 2008 May 29;199(4):637–650. doi: 10.1007/s00213-008-1183-y

Figure 2.

Figure 2

Monoamine levels in neostriatum (A – D) and hippocampus (E – F) 3 days following MA exposure. MA-treated animals regardless of regimen demonstrated decreased levels of (A) DA, (B) DOPAC, (C) 5-HT, and (D) 5-HIAA in the neostriatum and decreased (E) 5-HT and (F) 5-HIAA in the hippocampus. In addition, SAL-15min animals displayed increased hippocampal (E) 5-HT and (F) 5-HIAA compared to SAL-120min animals (SAL-120min n = 9 MA-120min n = 9, SAL-15min n = 9, MA-15min n = 9). open bar = SAL-120min, striped bar = SAL-15min, black bar = MA-120min, gray bar = MA-15min. * p ≤ 0.05 vs SAL, #p ≤ 0.05 vs SAL-120min.